5 research outputs found

    Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma

    No full text
    Rituximab plus chemotherapy has been shown to be effective in patients with advanced-stage, previously untreated follicular lymphoma; nevertheless, most patients will have a relapse. Combination immunotherapy with lenalidomide and rituximab is an immunomodulatory regimen that has shown promising activity in patients with indolent B-cell non-Hodgkin's lymphoma
    corecore